Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kimmelman

Showing results (31-40 of 192) with videos related to

Pageof 20
Sort By:
Perspectives in Biology and Medicine|January 8, 2021
What Is Human Research For? Reflections on the Omission of Scientific Integrity from the <i>Belmont Report</i>Jonathan Kimmelman
Academic Medicine : Journal of the Association of American Medical Colleges|January 2, 2007
Inventors as investigators: the ethics of patents in clinical trialsJonathan Kimmelman
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 21, 2007
Missing the forest: further thoughts on the ethics of bystander risk in medical researchJonathan Kimmelman
Clinical Trials (London, England)|October 13, 2012
The social function of clinical equipoiseJonathan Kimmelman
Medicine, Health Care, and Philosophy|February 3, 2016
How do researchers decide early clinical trials?Hannah Grankvist, Jonathan Kimmelman
Human Gene Therapy|May 6, 2005
Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trialsJonathan Kimmelman, Aaron Levenstadt
Perspectives in Biology and Medicine|July 11, 2017
The Research Optimist's DefenseDaniel Benjamin, Jonathan Kimmelman
Nature Reviews. Clinical Oncology|April 21, 2018
The paradox of precision medicineJonathan Kimmelman, Ian Tannock
Bioethics|November 3, 2010
The ethics of managing affective and emotional states to improve informed consent: autonomy, comprehension, and voluntarinessHillel Braude, Jonathan Kimmelman
Nature|February 3, 2017
Consider drug efficacy before first-in-human trialsJonathan Kimmelman, Carole Federico
Pageof 20

Showing results (31-40 of 192) with videos related to

Sort By:
Pageof 20
Perspectives in Biology and Medicine|January 8, 2021
What Is Human Research For? Reflections on the Omission of Scientific Integrity from the <i>Belmont Report</i>Jonathan Kimmelman
Academic Medicine : Journal of the Association of American Medical Colleges|January 2, 2007
Inventors as investigators: the ethics of patents in clinical trialsJonathan Kimmelman
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 21, 2007
Missing the forest: further thoughts on the ethics of bystander risk in medical researchJonathan Kimmelman
Clinical Trials (London, England)|October 13, 2012
The social function of clinical equipoiseJonathan Kimmelman
Medicine, Health Care, and Philosophy|February 3, 2016
How do researchers decide early clinical trials?Hannah Grankvist, Jonathan Kimmelman
Human Gene Therapy|May 6, 2005
Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trialsJonathan Kimmelman, Aaron Levenstadt
Perspectives in Biology and Medicine|July 11, 2017
The Research Optimist's DefenseDaniel Benjamin, Jonathan Kimmelman
Nature Reviews. Clinical Oncology|April 21, 2018
The paradox of precision medicineJonathan Kimmelman, Ian Tannock
Bioethics|November 3, 2010
The ethics of managing affective and emotional states to improve informed consent: autonomy, comprehension, and voluntarinessHillel Braude, Jonathan Kimmelman
Nature|February 3, 2017
Consider drug efficacy before first-in-human trialsJonathan Kimmelman, Carole Federico
Pageof 20